HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
41.36
-0.23 (-0.55%)
As of 9:49AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close41.59
Open41.61
Bid41.58 x 800
Ask41.63 x 1800
Day's Range41.32 - 41.69
52 Week Range35.10 - 45.09
Volume41,953
Avg. Volume2,096,515
Market Cap11.255B
Beta (3Y Monthly)0.88
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Simply Wall St.9 days ago

    Calculating The Fair Value Of Hologic Inc (NASDAQ:HOLX)

    In this article I am going to calculate the intrinsic value of Hologic Inc (NASDAQ:HOLX) by projecting its future cash flows and then discounting them to today’s value. I will Read More...

  • Women Health a Prime Concern Worldwide: 3 Stocks in Focus
    Zacks20 days ago

    Women Health a Prime Concern Worldwide: 3 Stocks in Focus

    Women health care gradually gaining importance globally, investors might keep an eye on a few stocks.

  • Hologic's Focal Therapeutics Buyout to Boost Breast Health Arm
    Zacks21 days ago

    Hologic's Focal Therapeutics Buyout to Boost Breast Health Arm

    Hologic (HOLX) progresses with initiatives to boost the Breast Health unit. The recent buyout is likely to widen portfolio and fortify Hologic's position in the breast conserving surgery market.

  • Benzinga21 days ago

    The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Sept. 26) Abbott Laboratories (NYSE: ABT ) Aldeyra Therapeutics ...

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit28 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding HOLX is favorable, with net inflows of $27.64 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.

  • Cynosure Headwinds Trigger Analyst Downgrades on HOLX Stock
    Market Realistlast month

    Cynosure Headwinds Trigger Analyst Downgrades on HOLX Stock

    Hologic (HOLX) is a medical technology company focused on women’s health with headquarters in Marlborough, Massachusetts. The company offers solutions across four segments including diagnostics, breast and skeletal health, gynecological surgery, and medical aesthetics. The company recently provided an update on the financial impact of its recently announced marketing and distribution suspension of its TempSure Vitalia handpiece and probes. We discussed the details in the previous article of this series. ...

  • Hologic’s Cynosure Headwinds Could Impact 2018 Earnings
    Market Realistlast month

    Hologic’s Cynosure Headwinds Could Impact 2018 Earnings

    On September 12, Hologic (HOLX) provided an update on the financial impact of the suspension of its marketing and distribution of the company’s Vitalia handpieces and probes, which it announced in August. The company issued form 8-k on August 13 reporting its decision to suspend the marketing and distribution of the company’s Tempsure Vitalia handpieces and probes. The device, part of the company’s Cynosure division, was recalled on FDA (U.S. Food and Drug Administration) concerns around this class of products, which are used for vaginal rejuvenation procedures. The FDA sent letters to certain companies that manufactured these kinds of devices.

  • A Look at Hologic Stock’s Recent Performance
    Market Realistlast month

    A Look at Hologic Stock’s Recent Performance

    On September 17, Hologic (HOLX) ended the day at $39.53. The stock was down ~0.3% from its previous trading day’s closing price of $39.64. The stock has recuperated some of the losses it saw during the first half of fiscal 2018. It witnessed a declining trend after reporting its 52-week high of $45.09 on January 9, 2018.

  • Benzingalast month

    Hologic Downgraded By BofA As Cynosure Headwinds Persist

    An 8-K filed late Wednesday suggests Hologic, Inc. (NASDAQ: HOLX )’s headed for harder times . The Analyst Bank of America Merrill Lynch analyst  Derik de Bruin downgraded Hologic from Buy to Neutral and ...

  • What Teleflex’s Valuation Trend Indicates
    Market Realistlast month

    What Teleflex’s Valuation Trend Indicates

    From January 2–28, 2018, Teleflex (TFX) stock rose from $254.73 to $287.65, which was its high point so far in 2018. During the broader market turmoil in February, it dipped to a low of $242.67 on March 1. Then it made a steady recovery to $280 in June but has corrected again to its current level of $248.

  • How Hologic’s Valuation Stacks Up with Peers
    Market Realistlast month

    How Hologic’s Valuation Stacks Up with Peers

    Hologic is a medical technology firm focused on developing solutions for women’s health. Year-to-date, Hologic stock is down ~9.6%. The event led to a ~4% decline in its stock price on August 13, when the announcement was made.

  • Hologic Stock Down ~9% Year-to-Date
    Market Realistlast month

    Hologic Stock Down ~9% Year-to-Date

    On September 6, Hologic (HOLX) ended the day at $38.74. The stock was marginally down from its previous day’s closing price of $39.04. Hologic stock hit a 52-week high of $45.09 at the start of this year, on January 9, 2018.

  • Analysts Still Bullish on Teleflex Stock
    Market Realistlast month

    Analysts Still Bullish on Teleflex Stock

    Teleflex’s (TFX) interest expenses increased from $19.89 million in the second quarter of 2017 to $26.65 million in the second quarter of 2018. Its income taxes, on the other hand, decreased from $12.1 million in the second quarter of 2017 to $9.58 million in the second quarter of 2018.

  • Understanding Teleflex’s Operational Performance
    Market Realistlast month

    Understanding Teleflex’s Operational Performance

    Teleflex’s (TFX) geographic segments include the United States, Europe, Asia, and other. Teleflex incurred a total cost of sales of $265.09 million in the second quarter of 2018 compared to $238.3 million in the second quarter of 2017. For fiscal 2018, Teleflex’s gross margins are expected to be 57.56% compared to 55.76% for fiscal 2017.

  • Analysts Project ~16.5% Upside in Hologic Stock
    Market Realistlast month

    Analysts Project ~16.5% Upside in Hologic Stock

    Hologic (HOLX) is a medical technology firm focused on improving women’s health. The company operates across four segments: diagnostics, GYN surgical, breast cancer, and skeletal health. The company reported strong Q3 2018 earnings results, which led to a rise in its stock price. In this article, let’s look at analysts’ recommendations for HOLX stock.

  • Hologic (HOLX) Down 4.8% Since Last Earnings Report: Can It Rebound?
    Zacks2 months ago

    Hologic (HOLX) Down 4.8% Since Last Earnings Report: Can It Rebound?

    Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • How Is Roche’s Diagnostics Segments Positioned in August?
    Market Realist2 months ago

    How Is Roche’s Diagnostics Segments Positioned in August?

    In Roche’s Diagnostics division, the Centralized Point of Care Solutions segment reported first-half revenues of 3.76 billion Swiss francs, reflecting ~6.0% YoY growth at CER (constant exchange rates). In the second quarter, Roche’s (RHHBY) Centralized and Point of Care Solutions reported revenues of 2.0 billion Swiss francs, which reflected ~9.0% YoY growth at CER.

  • Hologic Launches Fluent Fluid Management System, Widens Suite
    Zacks2 months ago

    Hologic Launches Fluent Fluid Management System, Widens Suite

    Hologic (HOLX) adopts initiatives to boost the GYN Surgical segment.

  • 7 Bargain Stocks in Today's Pricey Market
    Kiplinger2 months ago

    7 Bargain Stocks in Today's Pricey Market

    Investors can rummage through the cheapie bin, looking for stocks with ultralow price-earnings ratios. But buying so-called deep value stocks isn't for the faint of heart: Their shares tend to be inexpensive because of a downturn in their business, and they may not rebound soon. Yet bargain hunters aren't entirely out of luck. Banks and other financial firms, for instance, trade at an average 36% discount to Standard & Poor's 500-stock index, based on the stocks' book value (assets minus liabilities), according to Bank of America Merrill Lynch. Some media companies also look inexpensive, along with technology firms that aren't as pricey as the stars of the tech world but still have strong prospects. The following seven stocks are bargains you can bet on for the long term. Our picks are profitable and leaders in their fields, but their shares trade at reasonable prices because of pressures in their industry or company-specific challenges. Eventually, we think those issues will subside. And for now, investors can buy these stocks at an attractive discount to the broad market or to industry averages. That should help set up strong returns, even if the stocks' prices rise only enough to get back to long-term average valuations. SEE ALSO: The 10 Best Stocks for GOP Tax Reform

  • Associated Press2 months ago

    Nielsen and Sysco climb while VF and Dycom slip

    Stocks that moved substantially or traded heavily Monday: VF Corp., down $3.47 to $92.82 The clothing company said it will make its denim business a separate company and focus on activewear and outdoor ...

  • MarketWatch2 months ago

    Hologic's stock drops after suspension of marketing of Vitalia TempSure device

    Shares of Hologic Inc. (holx) fell 2.9% in premarket trade Monday, after the company said its Cynosure division will suspend marketing and distribution of its Vitalia TempSure device for heating of vaginal tissue, while it considers the Food and Drug Administration's concerns over "vaginal rejuvenation" procedures using energy-based devices. Cynosure received a letter from the FDA relating to its MonaLisa Touch laser, but although the letter didn't mention Vitalia, has elected to consider the concerns and is asking customers to return purchased devices.

  • Hologic’s Medical Aesthetics Segment: Revenues Up in Fiscal Q3
    Market Realist2 months ago

    Hologic’s Medical Aesthetics Segment: Revenues Up in Fiscal Q3

    In the fiscal third quarter, Hologic (HOLX) reported revenues of ~$91.7 million for its Medical Aesthetics segment. This is a YoY (year-over-year) decline of 18.0% on a constant currency basis. However, the business reported a sequential rise in revenues in the fiscal third quarter. 

  • Hologic CEO on fighting breast cancer
    CNBC Videos17 days ago

    Hologic CEO on fighting breast cancer

    As Breast Cancer Awareness Month kicks off, Hologic CEO Steve MacMillan speaks to "Squawk Box" about the company's new imaging tech to better help detect cancer.

  • NYSE trader: I like tech stocks like Apple and Amazon that are household names
    Yahoo Finance Video2 months ago

    NYSE trader: I like tech stocks like Apple and Amazon that are household names

    Jonathan Corpina of Meridian Equity Partners joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves. Here's the performance of the Nasdaq 100 component stocks as of 2:30 pm ET: MELI Mercadolibre Inc 3.52% NVDA Nvidia Corp 3.11% TTWO Take-Two Interactive Software 2.33% ATVI Activision Blizzard Inc 2.10% NFLX Netflix Inc 1.88% ADBE Adobe Systems 1.48% ADI Analog Devices 1.36% ALGN Align Tech 1.32% BMRN Biomarin Pharmaceutical 1.26% BKNG(HB) Booking Hldgs Inc 1.22% IDXX Idexx Laboratories 1.16% STX(HB) Seagate Tech 1.08% HOLX Hologic Inc 1.05% ADSK Autodesk, Inc 1.01% ILMN Illumina Inc 0.99% WDAY Workday Inc 0.95% MSFT Microsoft Corp 0.88% CHKP Check Point Software Tech 0.81% PYPL PayPal Hldgs Inc 0.80% CTXS Citrix Systems Inc 0.81% ISRG Intuitive Surgical 0.79% TXN Texas Instruments 0.78% AMZN Amazon.com Inc 0.77% MU Micron Tech 0.70% NTES Netease Inc Ads 0.67% GILD Gilead Sciences 0.71% SIRI Sirius XM Hldgs Inc 0.65% SYMC(E) Symantec Corp 0.66% CDNS Cadence Design Systems 0.64% XLNX Xilinx Inc 0.66% CSCO Cisco Systems 0.48% ROST Ross Stores 0.51% KLAC KLA-Tencor Corp 0.49% BIIB Biogen Inc 0.44% SNPS Synopsys Inc 0.49% AMGN Amgen Inc 0.47% HAS Hasbro Inc 0.46% VRTX Vertex Pharmaceuticals 0.44% EBAY eBay Inc 0.43% ALXN Alexion Pharmaceuticals 0.45% CTSH Cognizant Tech Solutions'A' 0.43% GOOG Alphabet Inc Cl C Cap Stock 0.40% FISV Fiserv Inc 0.42% HSIC Henry Schein Inc 0.41% COST Costco Wholesale Corp 0.39% INTU Intuit Inc 0.32% QCOM Qualcomm Inc 0.35% REGN Regeneron Pharmaceuticals 0.30% ESRX Express Scripts Hldg Co 0.30% FB Facebook Inc 0.30% BIDU Baidu Inc 0.25% ADP Automatic Data Proc 0.26% EA Electronic Arts, Inc. 0.28% GOOGL Alphabet Inc Cl A 0.23% CTAS Cintas Corp 0.20% SHPG Shire plc ADS 0.18% VRSK Verisk Analytics Inc 0.14% PAYX Paychex Inc 0.10% FOXA(F) Twenty-First Century Fox Inc A 0.10% MCHP Microchip Tech 0.05% FOX(F) Twenty-First Century Fox Inc B 0.00% AAPL Apple Inc -0.02% SWKS Skyworks Solutions -0.06% FAST Fastenal Co -0.05% ORLY O'Reilly Automotive, Inc. -0.06% ASML ASML Hldg N.V. New York -0.10% VOD Vodafone Grp Plc ADS -0.10% JBHT Hunt(J.B.)Transport -0.05% WYNN Wynn Resorts Ltd -0.22% INCY Incyte Corp -0.23% MXIM Maxim Integrated Prod -0.24% CA CA Inc -0.27% PCAR PACCAR Inc -0.29% CERN Cerner Corp -0.43% CMCSA Comcast Cl A -0.45% MYL Mylan NV -0.48% KHC The Kraft Heinz Company -0.55% XRAY Dentsply Sirona Inc -0.55% CELG Celgene Corp -0.59% LBTYA Liberty Global plc Cl A -0.62% TSLA Tesla Inc -0.59% LRCX Lam Research -0.75% WBA Walgreen Boots Alliance Inc -0.71% MAR Marriott Int'l Cl A -0.84% MDLZ Mondelez Int'l Inc Cl A -0.88% CTRP Ctrip.com Intl Ltd -0.89% CSX CSX Corp -0.99% DISH DISH Network Corp Cl A -1.04% AVGO Broadcom Inc -1.11% LBTYK Liberty Global plc Cl C -1.09% INTC Intel Corp -1.17% QRTEA Qurate Retail Inc -1.17% WDC Western Digital -1.25% MNST Monster Beverage Corporation -1.33% DLTR Dollar Tree Inc -1.37% CHTR Charter Communications Inc -1.37% TMUS T-Mobile US Inc -1.43% JD JD.com Inc -1.40% AMAT Applied Materials -1.58% EXPE(F) Expedia Grp Inc -1.94% SBUX Starbucks Corp -2.24% AAL American Airlines Grp inc -2.38% ULTA Ulta Beauty Inc -3.14%